EPO Patents = 1

Forward Citations = 3

Loading Chart...

16 inventors (with patents filed for the assignee):

Jerry Ting (5 out of 5 patents)

Tong-Hsuan Chang (5 out of 5 patents)

Shu-Yen Chang (5 out of 5 patents)

4. Liahng-Yirn Liu (4 out of 5 patents)

5. Mei-Chun Yang (4 out of 4 patents)

6. Yu-Yu Lin (3 out of 74 patents)

7. Yen-Ying Chen (3 out of 3 patents)

8. Shu-Lun Tang (3 out of 3 patents)

9. Chia-Hao Chang (1 out of 15 patents)

10. Mei-Chin Yang (1 out of 2 patents)

11. Tsai-Hsia Hong (1 out of 1 patent)

12. Ying-Jin Chen (1 out of 1 patent)

13. Jaw-Yuan Wen (1 out of 1 patent)

14. Kazuko Handa (1 out of 6 patents)

15. Sen-itiroh Hakomori (1 out of 25 patents)

5 patents: Sort by Forward Citations

1. 12753242 - ANTIBODY CONJUGATES AND USES THEREOF (2026-10-06),

2. 11643471 - Therapeutic antibodies (2023-05-09),

3. 11440967 - Therapeutic antibodies (2022-09-13),

4. 8703129 - Antibodies against extended type 1 chain antigens, derivatives thereof and use (2014-04-22),

5. 8163497 - Anti-extended type I glycosphingolipid antibody, derivatives thereof and use (2012-04-24),

Glyconex, Inc. is a biotechnology company specializing in the development and production of complex carbohydrates for use in pharmaceuticals, research, and other applications. Our innovative glycan-related products and services are designed to enhance drug efficacy, improve diagnostics, and advance scientific research. With a focus on quality, reliability, and customization, Glyconex is committed to providing cutting-edge solutions tailored to meet the unique needs of our clients.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#778 in Taipei

#2,365 in Taiwan

Taipei, Taiwan

Glyconex, Inc.